ACTIVE: Activity Therapy to Increase Veteran Engagement
ACTIVE
A Feasibility Study of Behavioral Activation in the Rehabilitation of Veterans With Post-TBI Depression
1 other identifier
interventional
46
1 country
1
Brief Summary
Depression is common after traumatic brain injury (TBI) and may have wide-ranging consequences. Post-TBI depression may impede reintegration into the family and community and lead to lower quality of life and heightened suicide risk. It may also interfere with rehabilitation. Yet, current treatments for post-TBI depression are based largely on expert opinion rather than evidence from rigorous studies. Behavioral activation (BA) is a promising intervention for post-TBI depression. It is a brief behavioral treatment that helps people define goals, create and execute plans to reach them, and engage in meaningful activities. BA has been tested in clinical trials since the 1970s and has been shown to reduce or prevent depression in populations with diverse medical conditions. However, BA has rarely been used or studied for treatment of depression in a TBI population. The investigators will conduct a study of BA with at least 40 Veterans with TBI and depressive symptoms in VA outpatient rehabilitation care. One group of Veterans will be randomly assigned to receive BA plus usual care. The BA program consists of six sessions delivered over three months at the VA (or Veterans' homes, if preferred) by an occupational therapist (OT). A second group of Veterans will be randomly assigned to receive usual care. The investigators will assess the feasibility of delivering the BA intervention in the rehabilitation setting and its acceptability to Veterans and staff. The research team will also assess participant responses to BA in the outcomes of depressive symptoms, community reintegration, and quality of life. Study findings will be used to guide the development of a future study of BA in a larger sample of Veterans with post-TBI depression. This study and future research may add a powerful clinical tool to rehabilitation services to lessen or prevent depression in Veterans with TBI. Reducing depression may in turn facilitate rehabilitation and enhance community reintegration, allowing Veterans to engage more fully in their families and communities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 26, 2021
CompletedStudy Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2024
CompletedResults Posted
Study results publicly available
September 22, 2025
CompletedDecember 12, 2025
November 1, 2025
2.2 years
July 1, 2021
April 28, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depressive Symptom Scores on CES-D
Depressive symptoms will be measured by The Center for Epidemiologic Studies Depression Scale (CES-D). CES-D is a well-established 20-item screening instrument that shows good psychometric properties in TBI populations. It will be administered at the Baseline interview and Follow-up interview (at 3 months). It uses a Likert-type scale from 0 to 3. The total score is the sum across all 20 items. Total scores may range from 0 to 60, with higher scores indicating greater depressive symptoms.
3 - 4 months
Secondary Outcomes (2)
Community Reintegration Scores on PART-O-17
3 - 4 months
Quality of Life in TBI Scores on QoL-TBI Instrument
3 - 4 months
Other Outcomes (5)
Acceptability of the Intervention Rated by the Interventionist
3 - 4 months
Veteran Acceptability/Satisfaction With the Intervention
3 - 4 months
Recruitment
16 months
- +2 more other outcomes
Study Arms (2)
Behavioral Activation (BA) intervention group
EXPERIMENTALParticipants in the BA group will receive BA treatment and treatment as usual. BA is a brief behavioral treatment that helps people define goals, create and execute plans to attain them, and engage in meaningful activities. The BA intervention will be delivered in 6 sessions over 3 months by Occupational Therapists trained in BA for post-TBI depression. BA sessions will be conducted in person in an office at the VA rehabilitation clinic, virtually by VA Video Connect, or in person in the home, depending on the veteran's preference.
Treatment as Usual Control Group
OTHERParticipants in the Control group receive treatment as usual (TAU), which is usual care provided by the VA medical center.
Interventions
BA is a brief behavioral treatment that helps people define goals, create and execute plans to attain them, and engage in meaningful activities. BA protocol components include: goal setting (especially for activities that promote social connectedness), creation of a plan (broken down into steps), strategies for implementation of steps, identification of potential barriers, tactics to overcome them, activity monitoring and scheduling, and emotion regulation strategies. The BA intervention will be delivered in 6 sessions over 3 months by Occupational Therapists trained in BA for post-TBI depression. BA sessions will be conducted in person in an office at the VA rehabilitation clinic, virtually by VA Video Connect, or in person in the home, depending on the veteran's preference.
Treatment as Usual refers to usual care provided by the VA medical center.
Eligibility Criteria
You may qualify if:
- Veteran enrolled in the outpatient Rehabilitation Medicine Service at the Corporal Michael J. Crescenz VA Medical Center
- Age of 21 years or older
- Meet professional criteria for mild or moderate TBI
- Confirmation of TBI diagnosis
- Have a CES-D score at or above 16 at both the Telephone Screen and Baseline
- Those taking antidepressants or other medications affecting mood or behavior must have been using these for at least three months, to allow for stabilization.
- Those in psychotherapy can participate if therapy has been ongoing for three months or longer.
- Veterans report current TBI-related symptoms on the Telephone Screen.
- Speak English
You may not qualify if:
- A diagnosis of severe TBI
- Psychosis
- Aphasia
- History of bipolar disorder
- Presence of suicidal ideation with affirmative response on item 9 of the PHQ-9
- History of severe physical aggressiveness, judged by the clinical team
- Currently receiving Cognitive Behavioral Therapy for depression
- Dementia (determined on case-by-case basis based on physician diagnosis and participant's difficulty understanding interview questions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- Thomas Jefferson Universitycollaborator
Study Sites (1)
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Philadelphia, Pennsylvania, 19104-4551, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Helene Moriarty, PhD, RN
- Organization
- Corporal Michael J. Crescenz VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Helene J Moriarty, PhD RN
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Care providers at the medical center will not have knowledge of the intervention or control condition assigned to individual participants. The research interviewer at the follow-up interview (the outcome assessor) also has no knowledge of the intervention or control condition assigned to individual participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 26, 2021
Study Start
February 15, 2022
Primary Completion
April 16, 2024
Study Completion
June 3, 2024
Last Updated
December 12, 2025
Results First Posted
September 22, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- The IDP will be shared starting six months after the publication.
- Access Criteria
- We will consult with a VA privacy officer and other regulatory specialists at the Corporal Michael Crescenz VA Medical Center, taking all recommended steps to insure that re-identifying participants from the final de-identified and anonymous dataset will not be possible. In addition, the Data Use Agreement will explicitly prohibit attempts to re-identify participants.
Final data sets underlying all publications resulting from the research will be shared outside VA. A de-identified, anonymized dataset will be created and shared. A final dataset will be made available to the public upon receipt of a study-specific Data Use Agreement made in writing and following IRB and VA R\&D regulations. Data will be provided electronically and per VA regulations for transferring data.